Literature DB >> 34318182

Commentary: May the light guide your way.

Giye Choe1, Daniela Molena2.   

Abstract

Entities:  

Year:  2021        PMID: 34318182      PMCID: PMC8300963          DOI: 10.1016/j.xjtc.2021.01.032

Source DB:  PubMed          Journal:  JTCVS Tech        ISSN: 2666-2507


× No keyword cloud information.
LUL posterior segment with its pulmonary artery ligated appears dark after ICG injection. A large-scale retrospective study confirms that intravenous use of indocyanine green and near-infrared fluorescence imaging for definition of intersegmental planes is safe and effective. See Article page 151. As the thoracic surgery community encounters increasing numbers of patients who present with smaller (<2 cm) multifocal or ground-glass lesions, interest in segmentectomy continues to grow. Although the oncologic outcomes of segmentectomy versus lobectomy remain a matter of debate,1, 2, 3 there has been a renewed focus on the technical aspects of segmentectomy. One such technical challenge is delineation of the intersegmental borders of the target segment. Intersegmental planes have no anatomic landmarks, yet accurate resection margins are critical in ensuring the oncologic quality of the resection. A wide variety of methods have been studied that can be broadly categorized into selective insufflation, selective intravenous perfusion, and 3-dimensional imaging. Each method has its pros and cons; however, at present, most studies include sample sizes <100 and do not include a comparison of different techniques within the same study. Yotsukura and colleagues provide a retrospective review of their experience performing segmentectomy (N = 209) with intravenous indocyanine green (ICG) to delineate the intersegmental plane. Consistent with previous studies, they found good demarcation in nearly 90% of cases. They also analyzed results between simple and complex segmentectomies and describe concurrent use of high-frequency jet ventilation (HFJV) in 76.6% of cases, allowing a comparison of the 2 methods. Unsurprisingly, they found that, owing to collateral ventilation, HFJV was less precise and yielded larger resection margins—this was more notable in patients undergoing complex segmentectomy (which tends to involve a larger intersegmental surface area) and patients with chronic obstructive pulmonary disease. ICG outperformed HFJV even in these cases and, overall, had better demarcation. In addition to its established efficacy in this large cohort, ICG allows rapid onset of visualization (within 1 minute) and does not require an experienced bronchoscopist. We commend the authors on their consistent technique and excellent early surgical results. However, description of the 12% of patients deemed to have poor delineation may have added value, and the intraoperative methods used to determine the intersegmental planes in these cases and whether those patients had different outcomes would be worthwhile to know. Finally, although oncologic outcomes were not the focus of this study, we cannot help but notice that only 1 patient out of 186 with primary lung cancer was found to have positive nodal disease. Even with the best clinical judgment, this seems unusually low. Whether this is related to extraordinary patient selection or nodal sampling is unclear. In our experience, the use of ICG for intersegmental demarcation is convenient and reliable. Many thoracic surgery centers have near-infrared vision thoracoscopes that are also used to assess for perfusion in cases that involve a bowel anastomosis, such as esophagectomy. The da Vinci Xi (Intuitive, Sunnyvale, Calif) robotic system also has near-infrared capability (Firefly mode). As we anticipate further increases in the adoption of segmentectomy for lung cancers, the ease and accuracy of ICG give it a significant advantage for widespread implementation going forward—may the light guide your way!
  5 in total

1.  A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).

Authors:  Kenichi Nakamura; Hisashi Saji; Ryu Nakajima; Morihito Okada; Hisao Asamura; Taro Shibata; Shinichiro Nakamura; Hirohito Tada; Masahiro Tsuboi
Journal:  Jpn J Clin Oncol       Date:  2009-11-22       Impact factor: 3.019

2.  Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.

Authors:  Syed S Razi; Dao Nguyen; Nestor Villamizar
Journal:  J Thorac Cardiovasc Surg       Date:  2019-11-21       Impact factor: 5.209

Review 3.  Identification of the intersegmental plane during thoracoscopic segmentectomy: state of the art.

Authors:  Marco Andolfi; Rossella Potenza; Agathe Seguin-Givelet; Dominique Gossot
Journal:  Interact Cardiovasc Thorac Surg       Date:  2020-03-01

4.  Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Authors:  Nasser K Altorki; Xiaofei Wang; Dennis Wigle; Lin Gu; Gail Darling; Ahmad S Ashrafi; Rodney Landrenau; Daniel Miller; Moishe Liberman; David R Jones; Robert Keenan; Massimo Conti; Gavin Wright; Linda J Veit; Suresh S Ramalingam; Mohamed Kamel; Harvey I Pass; John D Mitchell; Thomas Stinchcombe; Everett Vokes; Leslie J Kohman
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

5.  Indocyanine green imaging for pulmonary segmentectomy.

Authors:  Masaya Yotsukura; Yu Okubo; Yukihiro Yoshida; Kazuo Nakagawa; Shun-Ichi Watanabe
Journal:  JTCVS Tech       Date:  2021-01-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.